featured
Efficacy of Insulin Degludec vs Insulin Detemir in Combination With Insulin Aspart in Pregnant Women With Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial
Lancet Diabetes Endocrinol 2023 Jan 06;[EPub Ahead of Print], ER Mathiesen, AC Alibegovic, R Corcoy, F Dunne, DS Feig, M Hod, T Jia, B Kalyanam, S Kar, A Kautzky-Willer, C Marchesini, RD Rea, P DammFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.